2020 Annual Meeting | S19 - Autonomic Disorders
| 03:30 PM - 03:42 PM | Abstract |
001 - Irwin Schatz Award for Autonomic Disorders
Horacio C. Kaufmann, MD, FAAN |
| 03:42 PM - 03:54 PM | Abstract |
002 - Effects of Once-Daily Ampreloxetine (TD-9855), a Norepinephrine Reuptake Inhibitor, on Blood Pressure in Subjects With Symptomatic Neurogenic Orthostatic Hypotension
Horacio C. Kaufmann, MD, FAAN |
| 03:54 PM - 04:06 PM | Abstract |
003 - Presentation, Causes, and Hemodynamic Features of Acquired Afferent Baroreflex Failure
Bhumika Balgobin, MD |
| 04:06 PM - 04:18 PM | Abstract |
004 - Differences and Similarities Between the Parkinsonian Variant of Multiple System Atrophy and Parkinson Disease in the Natural History Study of the Synucleinopathies
Patricio Millar Vernetti, MD |
| 04:18 PM - 04:30 PM | Abstract |
005 - Predicting Phenoconversion in Pure Autonomic Failure
Elizabeth A. Coon, MD, FAAN |
| Glen A. Cook, Jr., MD, FAAN | Dr. Cook has stock in Aspire Biopharma. An immediate family member of Dr. Cook has stock in Aspire Biopharma. |
| Melissa M. Cortez, DO | The institution of Dr. Cortez has received research support from NIH NINDS. The institution of Dr. Cortez has received research support from Dysautonomia International. Dr. Cortez has received personal compensation in the range of $500-$4,999 for serving as a Content Expert, Reviewer, DSMB with NIH RECOVER project. |
| Roy L. Freeman, MD | Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regenacy. Dr. Freeman has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurobo. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli-Lilly. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theravance. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Inhibikase. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Freeman has stock in Neurobo. Dr. Freeman has stock in Cutaneous NeuroDiagnostics. The institution of Dr. Freeman has received research support from NIH. The institution of Dr. Freeman has received research support from Theravance. The institution of Dr. Freeman has received research support from Biohaven. The institution of Dr. Freeman has received research support from Lundbeck. |
| No disclosure on file | |
| Christopher H. Gibbons, MD, FAAN | Dr. Gibbons has received personal compensation for serving as an employee of CND Life Sciences. Dr. Gibbons has stock in CND Life Sciences. Dr. Gibbons has received publishing royalties from a publication relating to health care. Dr. Gibbons has received personal compensation in the range of $5,000-$9,999 for serving as a Expert Advisor with Department of Justice. |
| Gregor K. Wenning, MD | No disclosure on file |
| Steven Vernino, MD, PhD, FAAN | Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for antag. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Autonomic Neuroscience (Elsevier). The institution of Dr. Vernino has received research support from Takeda. The institution of Dr. Vernino has received research support from NIH/NHLBI. The institution of Dr. Vernino has received research support from Dysautonomia International. Dr. Vernino has received personal compensation in the range of $10,000-$49,999 for serving as a Content Expert Consultant with Office of Inspector General for Medicare. Dr. Vernino has a non-compensated relationship as a Board of Directors with American Autonomic Society that is relevant to AAN interests or activities. |
| Patricio Millar Vernetti, MD | The institution of Dr. Millar Vernetti has received research support from NIH. Dr. Millar Vernetti has received personal compensation in the range of $500-$4,999 for serving as a Speaker with WPC. Dr. Millar Vernetti has received personal compensation in the range of $0-$499 for serving as a Speaker with AAN. |
| Wolfgang Singer, MD, FAAN | Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UniQure. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theravance. The institution of Dr. Singer has received research support from NIH. The institution of Dr. Singer has received research support from FDA. The institution of Dr. Singer has received research support from Michael J. Fox Foundation. Dr. Singer has received intellectual property interests from a discovery or technology relating to health care. |
| Marcelo Merello | No disclosure on file |
| Amanda C. Peltier, MD, MS | Dr. Peltier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Dr. Peltier has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for astrazeneca. Dr. Peltier has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CSL Behring. Dr. Peltier has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Csl Behring. Dr. Peltier has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Peltier has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for alnylam. Dr. Peltier has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for astrazeneca. Dr. Peltier has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Goldman Ismail. The institution of Dr. Peltier has received research support from NIH. The institution of Dr. Peltier has received research support from CSL Behring. |
| Horacio C. Kaufmann, MD, FAAN | Dr. Kaufmann has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Theravance. Dr. Kaufmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Parexel. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Kaufmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curasen Therapeutics. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Kaufmann has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda Pharmaceuticals. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Spinger. The institution of Dr. Kaufmann has received research support from Biogen. The institution of Dr. Kaufmann has received research support from Vaxxinity. Dr. Kaufmann has received publishing royalties from a publication relating to health care. |
| Eduardo E. Benarroch, MD, FAAN | Dr. Benarroch has nothing to disclose. |
| Elizabeth A. Coon, MD, FAAN | Dr. Coon has nothing to disclose. |
| Paola Sandroni, MD, PhD, FAAN | Dr. Sandroni has nothing to disclose. |
| Jayawant N. Mandrekar, PhD | Dr. Mandrekar has nothing to disclose. |
| Sarah E. Berini, MD | Dr. Berini has nothing to disclose. |
| Phillip A. Low, MD, FAAN | Dr. Low has nothing to disclose. |
| Bhumika Balgobin, MD | No disclosure on file |
| Ross Vickery | Ross Vickery has nothing to disclose. |
| David S. Goldstein, MD, PhD | Dr. Goldstein has received publishing royalties from a publication relating to health care. |
| Jose-Alberto Palma, MD, PhD, FAAN | Dr. Palma has received personal compensation for serving as an employee of Novartis. Dr. Palma has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Clinical Autonomic Research. The institution of Dr. Palma has received research support from National Institutes of Health. Dr. Palma has received publishing royalties from a publication relating to health care. |
| Maria J. Marti | No disclosure on file |
| Alessandra Fanciulli, MD, PhD | Alessandra Fanciulli, MD, PhD has received personal compensation in the range of $0-$499 for serving as a Consultant for Theravance Biopharma. Alessandra Fanciulli, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Alessandra Fanciulli, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Theravance Biopharma. Alessandra Fanciulli, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Healthware. Alessandra Fanciulli, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Alessandra Fanciulli, MD, PhD has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Stopp-HSP. Alessandra Fanciulli, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Otto Loewi Society. Alessandra Fanciulli, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bial . Alessandra Fanciulli, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Alessandra Fanciulli, MD, PhD has received research support from Parkinson Fond. The institution of Alessandra Fanciulli, MD, PhD has received research support from Tuba Foundation. The institution of Alessandra Fanciulli, MD, PhD has received research support from MSA Coalition. The institution of Alessandra Fanciulli, MD, PhD has received research support from Austrian Exchange Programme. The institution of Alessandra Fanciulli, MD, PhD has received research support from Austrian Science Fund. Alessandra Fanciulli, MD, PhD has received publishing royalties from a publication relating to health care. |